Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study

Avatrombopag is a newly approved thrombopoietin receptor agonist for second-line treatment of chronic immune thrombocytopenia (ITP) in adults. Our previous study showed its efficacy and safety in a small sample of paediatric ITP patients. However, large samples and long-term data are still lacking....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of haematology 2025-01
Hauptverfasser:	Wang, Nan, Wang, Zhifa, Liu, Jingjing, Hu, Yu, Dong, Shuyue, Chen, Hui, Meng, Jinxi, Ma, Jingyao, Chen, Zhenping, Cheng, Xiaoling, Wu, Runhui
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!